Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07817108) titled 'Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Condition:
Varicella-zoster Virus
Intervention:
Biological: ABO1108
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: June 27, 2026
Target Sample Size: 18000
Countries of Recruitment:
China
To know more, visit https://cl...